Sentence examples for a favourable indicator from inspiring English sources

However, the role of MMP-9 is less clear than that of u-PA, as overexpression of MMP-9 in human breast cancer was reported to be a favourable indicator in node-negative patients (Scorilas et al, 2001).

Olive oil, the most commonly used seasoning fat and the main source of monounsaturated fatty acid in Mediterranean countries, has also been reported to be a favourable indicator of various common cancers (Pelucchi et al, 2011), although data on pancreatic cancer are scanty (La Vecchia and Negri, 1997).

A drop in CEA levels after the resection is considered a favourable indicator of the completeness of the surgical excision (Herrera et al, 1976), although CEA concentration is generally regarded as more sensitive for hepatic and retroperitoneal metastases than for local recurrence or peritoneal and pulmonary metastases (Crawford et al, 2003).

We also demonstrated a statistically significant correlation with ERb status which is a favourable prognostic indicator in human breast cancer.

Response to neo-adjuvant chemotherapy is a favourable prognostic indicator and can be used to select patients for radiotherapy allowing bladder preservation in >80% of the selected patients.

However, the finding that TPD52 is a favourable prognostic indicator in ovarian carcinoma patients contrasts with findings obtained in breast cancer [ 12].

In colorectal and ovarian cancers, a high proportion of CD8+ T cells or CD45RO+ memory T cells infiltrating the cancer tissue can be a favourable prognostic indicator (Zhang et al, 2003; Pages et al, 2005).

Expression of PR has been reported to be a favourable prognostic indicator in ovarian cancer (Lee et al. 2005), but this finding may be misleading due to the inclusion of multiple histotypes in the analysis.

It appears that serum PSA in women does not have potential for breast cancer diagnosis or monitoring, but our previous data are consistent with the view that tumour PSA concentration is a favourable prognostic indicator in women with breast cancer.

Response to neo-adjuvant chemotherapy is a favourable prognostic indicator and can be used to select patients for radiotherapy allowing bladder preservation in approximately 70% of patients with survival comparable to recent surgical series.

At the same time, by using the largest patient/control cohort to date, and a robust and reliable PCR-based assay, we have shown that the 2G polymorphism in the MMP-1 promoter was a favourable prognostic indicator in patients with CRC as measured by a 5-year survival.